| abstract |
The present invention uses a property of an antibody / peptide-nucleic acid complex to induce immune-mediated death signaling and direct death-signaling cross-activation in target cells. Disclose the thing. This complex can simultaneously activate multiple death signaling mechanisms. Disclosed are methods of using the conjugates of the invention as immunotherapy to treat or prevent infections, neoplastic disorders, or other diseases. |